These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 750780)

  • 1. [Pharmacokinetics and pharmacogenetics of isoniazid: theoretical and practical importance].
    Benomar S
    Maghrib Tibbi; 1978 Oct; 1(1):83-8. PubMed ID: 750780
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid and psuedocholinesterase polymorphisms.
    La Du BN
    Fed Proc; 1972; 31(4):1276-85. PubMed ID: 4556778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of isonicotinic acid hydrazide (INH) in the body of pregnant rats].
    Junosza-Szaniawska J; Wierzba K
    Acta Pol Pharm; 1980; 37(6):693-8. PubMed ID: 7293808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sulfalene pharmacogenetics. II. The population genetic aspect].
    Kholodov LE; Lil'in ET; Meksin VA; Vaniukov MM
    Genetika; 1979 Dec; 15(12):2210-4. PubMed ID: 510916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of isoniazid in chronic kidney failure].
    Titarenko OT; Vakhmistrova TI; Perova TL; Morozov NV
    Vrach Delo; 1983 Apr; (4):19-22. PubMed ID: 6868525
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid pharmacokinetics in patients in chronic renal failure.
    Gold CH; Buchanan N; Tringham V; Viljoen M; Strickwold B; Moodley GP
    Clin Nephrol; 1976 Aug; 6(2):365-9. PubMed ID: 954244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid pharmacokinetics in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    S Afr Med J; 1979 Aug; 56(8):299-300. PubMed ID: 550491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetic research in clinical psychiatry].
    Diukov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Apr; 76(4):597-604. PubMed ID: 779360
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of isoniazid half-life from salivary samples.
    Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):18-22. PubMed ID: 3957485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetics: theoretical and practical aspects].
    Paoletti V; Parlapiano C; Mucci N
    Ann Ist Super Sanita; 1983; 19(2-3):241-56. PubMed ID: 6398641
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid.
    Cohen LK; George W; Smith R
    Arch Dermatol; 1974 Mar; 109(3):377-81. PubMed ID: 4273616
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical importance of pharmacogenetics.
    Becker CE
    Calif Med; 1969 Oct; 111(4):291-7. PubMed ID: 5347202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new isoniazid preparation designed for moderately fast and "fast" metabolizers of the drug.
    Eidus L; Hodgkin MM
    Arzneimittelforschung; 1975 Jul; 25(7):1077-80. PubMed ID: 1101901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatotoxic effect of isoniazid (clinical, genetic and metabolic aspects)].
    Chrostowski K; Kanabus P
    Pneumonol Pol; 1977; 45(1):49-54. PubMed ID: 834577
    [No Abstract]   [Full Text] [Related]  

  • 18. No interaction between H2 blockers and isoniazid.
    Paulsen O; Höglund P; Nilsson LG; Gredeby H
    Eur J Respir Dis; 1986 Apr; 68(4):286-90. PubMed ID: 2874048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics.
    Evans DA
    Trans Med Soc Lond; 1970; 86():72-81. PubMed ID: 5531297
    [No Abstract]   [Full Text] [Related]  

  • 20. [New findings in the biotransformation and pharmacokinetics of antitubercular agents].
    Ritter W
    Prax Pneumol; 1973 Mar; 27(3):139-45. PubMed ID: 4121631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.